Free Trial

Canopy Growth (TSE:WEED) Trading Down 6.3% - Should You Sell?

Canopy Growth logo with Medical background

Canopy Growth Corp (TSE:WEED - Get Free Report)'s share price dropped 6.3% during trading on Tuesday . The company traded as low as C$1.48 and last traded at C$1.50. Approximately 1,915,596 shares traded hands during trading, an increase of 6% from the average daily volume of 1,805,645 shares. The stock had previously closed at C$1.60.

Analysts Set New Price Targets

Separately, ATB Capital decreased their target price on Canopy Growth from C$3.20 to C$1.60 and set an "underperform" rating for the company in a report on Tuesday, June 3rd.

Check Out Our Latest Stock Report on Canopy Growth

Canopy Growth Stock Performance

The business has a fifty day simple moving average of C$1.93 and a 200-day simple moving average of C$2.16. The company has a quick ratio of 2.32, a current ratio of 1.39 and a debt-to-equity ratio of 120.38. The firm has a market cap of C$239.69 million, a P/E ratio of -0.22, a P/E/G ratio of -0.01 and a beta of 1.79.

Insider Transactions at Canopy Growth

In other Canopy Growth news, Director David Angelo Lazzarato sold 15,701 shares of the stock in a transaction on Monday, June 30th. The stock was sold at an average price of C$1.68, for a total value of C$26,307.34. Company insiders own 0.21% of the company's stock.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Further Reading

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines